Division of Infectious Diseases

May 28, 2025

VUMC infectious disease experts explain what antibiotic resistance means for individuals and populations — and how to protect against it

A rising global health threat, antibiotic resistance presents several complications, but protection is possible.

By Evan Dorian
Ban Mishu Allos, MD. (photo by Donn Jones)
May 20, 2025

Ban Mishu Allos receives coveted Shovel Award

The recipient of the 2025 Shovel Award is Ban Mishu Allos, MD, associate professor of Medicine in the Division of Infectious Diseases.

By Jill Clendening
Bryan Harris, MD, MPH, MMHC. (photo by Susan Urmy)
April 28, 2025

Bryan Harris named interim chair of the Department of Medicine

Harris succeeds Jane Freedman, MD, as she assumes the role of Deputy CEO and Chief Health System Officer.  

By Bill Snyder
April 10, 2025

$4.1 million grant awarded to study unnecessary antibiotic prescriptions 

Antibiotic prescriptions handed out in unplanned care spaces contribute to antimicrobial resistance, especially if they are not necessary to treat infections.

By Evan Dorian
(iStock)
January 23, 2025

$20 million grant supports sweeping study of human viruses

Most of the more than 200 species of viruses known to reside in humans remain poorly understood, and new ones are being discovered every few months.

By Paul Govern
Kelly Dooley, MD, PhD, MPH. (photo by Susan Urmy)
January 13, 2025

VUMC’s Kelly Dooley joins clinical pharmacology board

ASCPT counts itself the largest scientific and professional organization serving the disciplines of clinical pharmacology and translational science.

By Paul Govern
October 21, 2024

Anna Person honored for teaching by Infectious Diseases Society of America

Person, an award citation reads in part, “has been a champion for empathy and equity in caring for patients. ... She models for her learners how to compassionately care.”
By Paul Govern
October 16, 2024

Study of severe drug reactions finds skin cells activate their own assassins

Single-cell analysis reveals the inner workings of the life-threatening adverse drug reactions Stevens-Johnson syndrome and toxic epidermal necrolysis.
By Paul Govern
September 11, 2024

Kelly Dooley’s TB research receives MERIT Award from the NIH  

Researchers must continually chase funding for their work. Kelly Dooley's prestigious award from the NIH is intended to help provide respite from that chase.
By Paul Govern
September 4, 2024

Bacterial metabolism plays role in staph antibiotic tolerance

Staph is a leading bacterial cause of death from bloodstream, bone and joint infections, in part because of high rates of antibiotic treatment failure.
By Leigh MacMillan
July 25, 2024

New study to explore infection response in diabetes

With a $3 million research grant, Henrique Serezani will investigate how altered metabolism in diabetes affects inflammation and sepsis.
By Paul Govern
July 23, 2024

VUMC joins $31 million project to speed new TB therapies

Sweeping data integration and clinical trial simulations are needed to help decide which targets to prioritize in researching new tuberculosis treatment regimens.
By Paul Govern
July 11, 2024

Jennifer Gaddy receives grants from March of Dimes, Burroughs Wellcome Fund

She studies infection of the female reproductive tract in the context of pregnancy.
By Paul Govern
1 2 3 … 13